» Articles » PMID: 23579930

Comparison of in Vivo Optical Systems for Bioluminescence and Fluorescence Imaging

Overview
Journal J Fluoresc
Specialties Biophysics
Chemistry
Date 2013 Apr 13
PMID 23579930
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo optical imaging has become a popular tool in animal laboratories. Currently, many in vivo optical imaging systems are available on the market, which often makes it difficult for research groups to decide which system fits their needs best. In this work we compared different commercially available systems, which can measure both bioluminescent and fluorescent light. The systems were tested for their bioluminescent and fluorescent sensitivity both in vitro and in vivo. The IVIS Lumina II was found to be most sensitive for bioluminescence imaging, with the Photon Imager a close second. Contrary, the Kodak system was, in vitro, the most sensitive system for fluorescence imaging. In vivo, the fluorescence sensitivity of the systems was similar. Finally, we examined the added value of spectral unmixing algorithms for in vivo optical imaging and demonstrated that spectral unmixing resulted in at least a doubling of the in vivo sensitivity. Additionally, spectral unmixing also enabled separate imaging of dyes with overlapping spectra which were, without spectral unmixing, not distinguishable.

Citing Articles

BrightMice: a low-cost do-it-yourself instrument, designed for in vivo fluorescence mouse imaging.

Boitet M, Achek A, Bouchenaki K, Grailhe R Sci Rep. 2024; 14(1):22685.

PMID: 39349676 PMC: 11442974. DOI: 10.1038/s41598-024-73130-3.


Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy.

Swingle K, Hamilton A, Mitchell M Placenta. 2024; .

PMID: 39181830 PMC: 11822046. DOI: 10.1016/j.placenta.2024.08.007.


Two-color diffuse flow cytometer.

Williams A, Scorzo A, Strawbridge R, Davis S, Niedre M J Biomed Opt. 2024; 29(6):065003.

PMID: 38818515 PMC: 11138342. DOI: 10.1117/1.JBO.29.6.065003.


Orthotopic and metastatic tumour models in preclinical cancer research.

Stribbling S, Beach C, Ryan A Pharmacol Ther. 2024; 257:108631.

PMID: 38467308 PMC: 11781865. DOI: 10.1016/j.pharmthera.2024.108631.


Plasmonic silver and gold nanoparticles: shape- and structure-modulated plasmonic functionality for point-of-caring sensing, bio-imaging and medical therapy.

Hang Y, Wang A, Wu N Chem Soc Rev. 2024; 53(6):2932-2971.

PMID: 38380656 PMC: 11849058. DOI: 10.1039/d3cs00793f.


References
1.
Dufort S, Sancey L, Wenk C, Josserand V, Coll J . Optical small animal imaging in the drug discovery process. Biochim Biophys Acta. 2010; 1798(12):2266-73. DOI: 10.1016/j.bbamem.2010.03.016. View

2.
Licha K, Olbrich C . Optical imaging in drug discovery and diagnostic applications. Adv Drug Deliv Rev. 2005; 57(8):1087-108. DOI: 10.1016/j.addr.2005.01.021. View

3.
Deliolanis N, Kasmieh R, Wurdinger T, Tannous B, Shah K, Ntziachristos V . Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J Biomed Opt. 2008; 13(4):044008. PMC: 2749214. DOI: 10.1117/1.2967184. View

4.
Chamberland D, Jiang Y, Wang X . Optical imaging: new tools for arthritis. Integr Biol (Camb). 2010; 2(10):496-509. PMC: 3677721. DOI: 10.1039/b926506f. View

5.
Stanga P, Lim J, Hamilton P . Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology. 2003; 110(1):15-21; quiz 22-3. DOI: 10.1016/s0161-6420(02)01563-4. View